These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29941599)

  • 1.
    Lo PW; Shie JJ; Chen CH; Wu CY; Hsu TL; Wong CH
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7302-7307. PubMed ID: 29941599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation regulates EZH2 protein stability and function.
    Chu CS; Lo PW; Yeh YH; Hsu PH; Peng SH; Teng YC; Kang ML; Wong CH; Juan LJ
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1355-60. PubMed ID: 24474760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
    Zhang S; Roche K; Nasheuer HP; Lowndes NF
    J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
    Jiang M; Xu B; Li X; Shang Y; Chu Y; Wang W; Chen D; Wu N; Hu S; Zhang S; Li M; Wu K; Yang X; Liang J; Nie Y; Fan D
    Oncogene; 2019 Jan; 38(3):301-316. PubMed ID: 30093632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase.
    Jani KS; Jain SU; Ge EJ; Diehl KL; Lundgren SM; Müller MM; Lewis PW; Muir TW
    Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8295-8300. PubMed ID: 30967505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
    Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis.
    Fang N; Li P
    Life Sci; 2021 Jun; 274():119226. PubMed ID: 33609540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1-C activates EZH2 expression and function in human cancer cells.
    Rajabi H; Hiraki M; Tagde A; Alam M; Bouillez A; Christensen CL; Samur M; Wong KK; Kufe D
    Sci Rep; 2017 Aug; 7(1):7481. PubMed ID: 28785086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
    Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
    Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc and EZH2-mediated epigenetic regulation of gene expression during consolidation of fear memories.
    Butler AA; Sanchez RG; Jarome TJ; Webb WM; Lubin FD
    Learn Mem; 2019 Sep; 26(9):373-379. PubMed ID: 31416910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.
    Ko HW; Lee HH; Huo L; Xia W; Yang CC; Hsu JL; Li LY; Lai CC; Chan LC; Cheng CC; Labaff AM; Liao HW; Lim SO; Li CW; Wei Y; Nie L; Yamaguchi H; Hung MC
    Oncotarget; 2016 Aug; 7(35):57131-57144. PubMed ID: 27494834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2.
    Wu QP; Vang S; Zhou JQ; Krick S; Barnes JW; Sanders YY
    J Cell Mol Med; 2024 Apr; 28(7):e18191. PubMed ID: 38494860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
    Chun YS; Kwon OH; Chung S
    Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
    Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
    Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A partially disordered region connects gene repression and activation functions of EZH2.
    Jiao L; Shubbar M; Yang X; Zhang Q; Chen S; Wu Q; Chen Z; Rizo J; Liu X
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16992-17002. PubMed ID: 32631994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A
    PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
    Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and identification of protein O-GlcNAcylation sites with substrate specificity.
    Wu HY; Lu CT; Kao HJ; Chen YJ; Chen YJ; Lee TY
    BMC Bioinformatics; 2014; 15 Suppl 16(Suppl 16):S1. PubMed ID: 25521204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation.
    Song X; Zhang L; Gao T; Ye T; Zhu Y; Lei Q; Feng Q; He B; Deng H; Yu L
    Biomed Pharmacother; 2016 Jul; 81():288-294. PubMed ID: 27261606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.